Skip to main content
Top
Published in: Pediatric Surgery International 5/2012

01-05-2012 | Original Article

Therapeutic outcome and prognosis in young patients with papillary and follicular thyroid cancer

Authors: Chung-Huei Huang, Tzu-Chieh Chao, Chuen Hseuh, Kun-Ju Lin, Tsung-Ying Ho, Shu-Fu Lin, Jen-Der Lin

Published in: Pediatric Surgery International | Issue 5/2012

Login to get access

Abstract

Background

Papillary and follicular thyroid cancer is a common malignancy in young patients, and the incidence of this cancer has been increasing. The aims of this study are to assess the clinical characteristics of papillary and follicular thyroid cancer in young patients and evaluate the long-term therapeutic outcomes and prognostic factors for cancer mortality and recurrence.

Methods

We performed a retrospective analysis of 116 patients aged ≤20 years who underwent thyroidectomy and a mean follow-up of 11.1 ± 0.6 years.

Results

There were 28 (24.1%) patients classified into the residual cancer or relapse groups. The progression-free survival rate for the young patients was lower than that of the patients between 20 and 45 years of age; however, the difference between the thyroid cancer survival rates was not statistically different. Two of the 28 patients died of thyroid cancer. Thirteen patients who showed relapsed underwent 131I whole-body scan; 6 of the 13 patients were diagnosed with distant metastases to the lung and 1 was diagnosed with distant metastases to the bones. Among the young patients, the 5- and 10-year progression-free survival rates were 79.1 and 73.4%, respectively, and the corresponding cancer survival rates were 99.1, and 96.5%, respectively.

Conclusion

The progression-free survival in young patients with papillary and follicular thyroid cancer was lower than the patients of age 20–45 years; otherwise, cancer survival was higher than age group over or equal to 45 years.
Literature
1.
go back to reference Alston RD, Geraci M, Eden TO et al (2008) Changes in cancer incidence in teenagers and young adults (ages 13 to 24 years) in England 1979–2003. Cancer 113:2715–2807CrossRef Alston RD, Geraci M, Eden TO et al (2008) Changes in cancer incidence in teenagers and young adults (ages 13 to 24 years) in England 1979–2003. Cancer 113:2715–2807CrossRef
2.
go back to reference Hogan AR, Zhuge Y, Perez EA et al (2009) Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. J Surg Res 156:167–172PubMedCrossRef Hogan AR, Zhuge Y, Perez EA et al (2009) Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. J Surg Res 156:167–172PubMedCrossRef
3.
4.
go back to reference Wada N, Sugino K, Mimura T et al (2009) Treatment strategy of papillary thyroid carcinoma in children and adolescents: clinical significance of the initial nodal manifestation. Ann Surg Oncol 16:3442–3449PubMedCrossRef Wada N, Sugino K, Mimura T et al (2009) Treatment strategy of papillary thyroid carcinoma in children and adolescents: clinical significance of the initial nodal manifestation. Ann Surg Oncol 16:3442–3449PubMedCrossRef
5.
go back to reference Parisi MT, Mankoff D (2007) Differentiated pediatric thyroid cancer: correlates with adult disease, controversies in treatment. Semin Nucl Med 37:340–356PubMedCrossRef Parisi MT, Mankoff D (2007) Differentiated pediatric thyroid cancer: correlates with adult disease, controversies in treatment. Semin Nucl Med 37:340–356PubMedCrossRef
6.
go back to reference Martin S, Ulrich C, Munsell M et al (2007) Delays in cancer diagnosis in underinsured young adults and older adolescents. Oncologists 12:816–824CrossRef Martin S, Ulrich C, Munsell M et al (2007) Delays in cancer diagnosis in underinsured young adults and older adolescents. Oncologists 12:816–824CrossRef
7.
go back to reference Hebestreit H, Biko J, Drozd V et al (2011) Pulmonary fibrosis in youth treated with radioiodine for juvenile thyroid cancer and lung metastases after Chernobyl. Eur J Nucl Med Mol Imaging 38:1683–1690PubMedCrossRef Hebestreit H, Biko J, Drozd V et al (2011) Pulmonary fibrosis in youth treated with radioiodine for juvenile thyroid cancer and lung metastases after Chernobyl. Eur J Nucl Med Mol Imaging 38:1683–1690PubMedCrossRef
8.
go back to reference Raval MV, Bentrem DJ, Stewart AK et al (2010) Utilization of total thyroidectomy for differentiated thyroid cancer in children. Ann Surg Oncol 17:2545–2553PubMedCrossRef Raval MV, Bentrem DJ, Stewart AK et al (2010) Utilization of total thyroidectomy for differentiated thyroid cancer in children. Ann Surg Oncol 17:2545–2553PubMedCrossRef
9.
go back to reference Takano T, Yane K, Oue T et al (2009) Outpatient administration of radioactive iodine after total thyroidectomy for pediatric thyroid cancer: a report of three cases. Int J Pediatr Otorhinolaryngol 73:1810–1813PubMedCrossRef Takano T, Yane K, Oue T et al (2009) Outpatient administration of radioactive iodine after total thyroidectomy for pediatric thyroid cancer: a report of three cases. Int J Pediatr Otorhinolaryngol 73:1810–1813PubMedCrossRef
10.
go back to reference Verburg FA, Biko J, Diessl S et al (2011) I-131 Activities as High as Safely Administrable (AHASA) for the treatment of children and adolescents with advanced differentiated thyroid cancer. J Clin Endocrinol Metab 96(8):E1268–E1271PubMedCrossRef Verburg FA, Biko J, Diessl S et al (2011) I-131 Activities as High as Safely Administrable (AHASA) for the treatment of children and adolescents with advanced differentiated thyroid cancer. J Clin Endocrinol Metab 96(8):E1268–E1271PubMedCrossRef
11.
go back to reference Sobin LH, UICC, Wittekind Ch (eds) (2002) TNM classification of malignant tumors, 6th edn. Wiley-Liss, New York, pp 52–56 Sobin LH, UICC, Wittekind Ch (eds) (2002) TNM classification of malignant tumors, 6th edn. Wiley-Liss, New York, pp 52–56
12.
go back to reference Delellis RA, Lloyd RV, Heitx PU et al (2004) Pathology and genetics of tumors of endocrine organs. In: World Health Organization classification of tumours. IARC, Lyon, pp 73–76 Delellis RA, Lloyd RV, Heitx PU et al (2004) Pathology and genetics of tumors of endocrine organs. In: World Health Organization classification of tumours. IARC, Lyon, pp 73–76
13.
go back to reference Huang BY, Lin JD, Chao TC et al (2011) Therapeutic outcomes of papillary thyroid cancer patients in different risk groups. Oncology 80:123–129PubMedCrossRef Huang BY, Lin JD, Chao TC et al (2011) Therapeutic outcomes of papillary thyroid cancer patients in different risk groups. Oncology 80:123–129PubMedCrossRef
14.
go back to reference Zhang DD, Zhou XH, Freeman DH et al (2002) A non-parametric method for the comparison of partial areas under ROC curves and its application to large health care data sets. Stat Med 21:701–715PubMedCrossRef Zhang DD, Zhou XH, Freeman DH et al (2002) A non-parametric method for the comparison of partial areas under ROC curves and its application to large health care data sets. Stat Med 21:701–715PubMedCrossRef
15.
go back to reference Bargren AE, Meyer-Rochow GY, Delbridge LW et al (2009) Outcomes of surgically managed pediatric thyroid cancer. J Surg Res 156:70–73PubMedCrossRef Bargren AE, Meyer-Rochow GY, Delbridge LW et al (2009) Outcomes of surgically managed pediatric thyroid cancer. J Surg Res 156:70–73PubMedCrossRef
16.
go back to reference Seybt MW, Terris DJ (2011) Minimally invasive thyroid surgery in children. Ann Otol Rhinol Laryngol 120:215–219PubMed Seybt MW, Terris DJ (2011) Minimally invasive thyroid surgery in children. Ann Otol Rhinol Laryngol 120:215–219PubMed
17.
go back to reference Steliarova-Foucher E, Stiller CA, Pukkala E et al (2006) Thyroid cancer incidence and survival among European children and adolescents (1978–1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 42:2150–2169PubMedCrossRef Steliarova-Foucher E, Stiller CA, Pukkala E et al (2006) Thyroid cancer incidence and survival among European children and adolescents (1978–1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 42:2150–2169PubMedCrossRef
18.
go back to reference Hay ID, Gonzalez-Losada T, Reinalda MS et al (2010) Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg 34:1192–1202PubMedCrossRef Hay ID, Gonzalez-Losada T, Reinalda MS et al (2010) Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg 34:1192–1202PubMedCrossRef
19.
go back to reference Lin JD, Chao TC, Hsueh C et al (2009) High recurrent rate of multi-centric papillary thyroid carcinoma. Ann Surg Oncol 16:2609–2616PubMedCrossRef Lin JD, Chao TC, Hsueh C et al (2009) High recurrent rate of multi-centric papillary thyroid carcinoma. Ann Surg Oncol 16:2609–2616PubMedCrossRef
20.
go back to reference Rodolico V, Cabibi D, Pizzolanti G et al (2007) BRAF (V600E) mutation and p27 (kip1) expression in papillary carcinomas of the thyroid ≤1 cm and their paired lymph node metastases. Cancer 110:1218–1226PubMedCrossRef Rodolico V, Cabibi D, Pizzolanti G et al (2007) BRAF (V600E) mutation and p27 (kip1) expression in papillary carcinomas of the thyroid ≤1 cm and their paired lymph node metastases. Cancer 110:1218–1226PubMedCrossRef
21.
go back to reference Lupi C, Giannini R, Ugolini C et al (2007) Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. J Clin Endocrinol Metab 92:4085–4090PubMedCrossRef Lupi C, Giannini R, Ugolini C et al (2007) Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. J Clin Endocrinol Metab 92:4085–4090PubMedCrossRef
22.
go back to reference Martinez-Tello FJ, Martinez-Cabruja R, Fernandez-Martin J et al (1993) Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods. Cancer 71:4022–4029PubMedCrossRef Martinez-Tello FJ, Martinez-Cabruja R, Fernandez-Martin J et al (1993) Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods. Cancer 71:4022–4029PubMedCrossRef
23.
go back to reference Furmanchuk AW, Roussak N, Ruchti C (1993) Occult thyroid carcinomas in the region of Minsk, Belarus. An autopsy study of 215 patients. Histopathology 23:319–325PubMedCrossRef Furmanchuk AW, Roussak N, Ruchti C (1993) Occult thyroid carcinomas in the region of Minsk, Belarus. An autopsy study of 215 patients. Histopathology 23:319–325PubMedCrossRef
24.
go back to reference Demidchik YE, Demidchik EP, Reiners C et al (2006) Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus. Ann Surg 243:525–532PubMedCrossRef Demidchik YE, Demidchik EP, Reiners C et al (2006) Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus. Ann Surg 243:525–532PubMedCrossRef
25.
go back to reference Lin JD, Lin KJ, Chao TC et al (2012) Clinical presentations of thyroid cancer patients with multiple primary cancers. J Endocrinol Invest 2011 May 24 (Epub ahead of print) Lin JD, Lin KJ, Chao TC et al (2012) Clinical presentations of thyroid cancer patients with multiple primary cancers. J Endocrinol Invest 2011 May 24 (Epub ahead of print)
26.
go back to reference Fallahi B, Adabi K, Majidi M et al (2011) Incidence of second primary malignancies during a long-term surveillance of patients with differentiated thyroid carcinoma in relation to radioiodine treatment. Clin Nucl Med 36:277–282PubMedCrossRef Fallahi B, Adabi K, Majidi M et al (2011) Incidence of second primary malignancies during a long-term surveillance of patients with differentiated thyroid carcinoma in relation to radioiodine treatment. Clin Nucl Med 36:277–282PubMedCrossRef
27.
go back to reference Wada N, Sugino K, Mimura T et al (2009) Pediatric differentiated thyroid carcinoma in stage I: risk factor analysis for disease free survival. BMC Cancer 9:306PubMedCrossRef Wada N, Sugino K, Mimura T et al (2009) Pediatric differentiated thyroid carcinoma in stage I: risk factor analysis for disease free survival. BMC Cancer 9:306PubMedCrossRef
28.
go back to reference Popovtzer A, Shpitzer T, Bahar G et al (2006) Thyroid cancer in children: management and outcome experience of a referral center. Otolaryngol Head Neck Surg 135:581–584PubMedCrossRef Popovtzer A, Shpitzer T, Bahar G et al (2006) Thyroid cancer in children: management and outcome experience of a referral center. Otolaryngol Head Neck Surg 135:581–584PubMedCrossRef
29.
go back to reference Kuo SF, Chao TC, Chang HY et al (2009) The role of radioactive iodine therapy in young patients with papillary thyroid cancer. Clin Nucl Med 34:4–6PubMedCrossRef Kuo SF, Chao TC, Chang HY et al (2009) The role of radioactive iodine therapy in young patients with papillary thyroid cancer. Clin Nucl Med 34:4–6PubMedCrossRef
Metadata
Title
Therapeutic outcome and prognosis in young patients with papillary and follicular thyroid cancer
Authors
Chung-Huei Huang
Tzu-Chieh Chao
Chuen Hseuh
Kun-Ju Lin
Tsung-Ying Ho
Shu-Fu Lin
Jen-Der Lin
Publication date
01-05-2012
Publisher
Springer-Verlag
Published in
Pediatric Surgery International / Issue 5/2012
Print ISSN: 0179-0358
Electronic ISSN: 1437-9813
DOI
https://doi.org/10.1007/s00383-012-3054-1

Other articles of this Issue 5/2012

Pediatric Surgery International 5/2012 Go to the issue